Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report

Stock Markets Aug 25, 2022 18:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
 
SIGA
-1.20%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.

By 2001, SIGA shares were faltering, and the company relied on grants.

After September 11, the federal government provided new funding for biodefense research.

As per Wall Street Journal, SIGA shifted its focus to drugs and vaccines to countermeasure bioterrorism attacks. SIGA received over $1 billion in government contracts to develop and manufacture a smallpox drug for the U.S. stockpile.

Like Bavarian Nordic AS (OTC: BVNRY), the only maker of a vaccine licensed for monkeypox, SIGA is mainly alone on one front of the response to an epidemic.

Related: Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies.

The company said it is juggling calls from governments worldwide, leading to $60 million in Tpoxx orders.

U.S. officials have made Tpoxx available for seriously ill monkeypox patients, drawing on its stockpile of 1.7 million treatment courses it acquired in case of a smallpox outbreak.

The Biden administration would make available 50,000 treatment courses to local health departments this week in addition to 20,000 courses sent previously.

Tpoxx was never tested in humans because smallpox was eradicated decades ago, instead on animals against viruses similar to smallpox, including monkeypox.

Tpoxx appears to be safe, and the animal data supports its use as an antiviral against monkeypox, doctors said.

Price Action: SIGA shares are down 10% at $18.93 on the last check Thursday.

Photo Jernej Furman from Flickr

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email